LithiumBank Resources

GH RESEARCH (NASDAQ: GHRS) STOCK QUOTE

Last Trade: US$12.09 -1.25 -9.37
Volume: 27,800
5-Day Change: 0.75%
YTD Change: -48.18%
Market Cap: US$628.920M

LATEST NEWS FROM GH RESEARCH

GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the first quarter ended March 31, 2022 and gave updates on its business. First Quarter 2022 Financial Highlights Cash position Cash was $270.8 million as of March 31, 2022, compared to $276.8 million as of December 31, 2021. We... Read More
GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2021 and gave updates on its business. Fourth Quarter 2021 Business Highlights In December 2021, we reported the successful outcome of the Phase 2 part of our Phase 1/2 clinical trial of GH001, our... Read More

COPYRIGHT ©2022 GREEN STOCK NEWS